Vornia Biomaterials designs, develops and fabricates customised biomaterial solutions for medical device manufacturers and providers who need to add differentiation to their products in the marketplace.

Management Team

Sean McMahon

Dr Sean McMahon (CEO)

As the CEO of Vornia Limited, Dr Sean McMahon is responsible for running all major facets of the business. Sean has a proven track record in the area of executive management with relevant technical experience in medical technologies and processes. Previously, Sean has served as Senior Scientist and Manufacture Manager at Vornia Limited and has developed Vornia’s significant intellectual property. Furthermore, he has successfully led cross functional teams through scale-up of next generation bio-material synthesis platforms to ISO 13485:2012 certified industrial scale GMP manufacture. Sean oversees management activities within the Company relating to Design, Manufacture, Quality Assurance, Procurement, Testing and Supply of Vornia’s products. He has a special interest in providing enhanced medical materials and is particularly interested in combining these bio-materials with intelligent business strategy to achieve commercially viable solutions that impact the clinical environment. He holds a PhD degree from the University College Dublin (UCD) and has been a catalyst in the growth and development of Vornia Limited since his appointment in 2013.

Udo Greiser

Dr Udo Greiser (Managing Director)

Managing Director, received his BS degree from the Ruhr-University Bochum (Germany) and his PhD degree from the Max-Planck-Group/ Friedrich Schiller University, Jena (Germany). He acquired further training and expertise in the areas of non-viral gene delivery, wound healing and stem cells (Cancer Centre, University of California, San Francisco and California Pacific Medical Center, San Francisco from 1997-2003; Regenerative Medicine Institute, REMEDI and Network of Excellence in Functional Biomaterials, NFB from 2004-2013; Charles Institute of Dermatology, University College Dublin from 2014-2015). He has several years of experience in the US industry as R&D scientist/manager, filed several patent applications and was awarded two commercialisation grants. He joined Vornia Biomaterials Ltd. In January 2015.

Wenxin Wang

Dr Wenxin Wang (Founder, CSO)

Dr Wenxin Wang has launched this spin-out company as one of the founders. Currently, Dr Wang is the Chairman of Director Board and CSO of Vornia Ltd. He has successfully commercialized 2 newly developed technologies onto the market (new PVDF polymerisation process; fast curing glass coatings/mirror back coatings). He is also Professor in Skin Research and Wound Healing at the Charles Institute of Dermatology, School of Medicine, University College Dublin as well as a Science Foundation Ireland (SFI) Principal Investigator.